Keywords: XR-NTX; extended release depot naltrexone; TAU; treatment as usual; OUD; opioid use disorders; Long acting naltrexone; Healthcare utilization; Opioid use disorders; Criminal justice population;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CI; Confidence interval; DRG; Diagnostic Related Group; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; ICD-10; International Classification of Diseases, Tenth Revision; HCUP NIS; Healthcare Cost and Utilization
Keywords: MAT; medication-assisted opioid therapy; OUD; opioid use disorder; TEDS-A; Treatment Episode Data Set-Admissions; Pharmacotherapy; Pregnancy; Opioid use disorder; Disparities;
Keywords: MAT; Medication assisted Treatment; NAS; Neonatal Abstinence Syndrome; NNNS; NICU Network Neurobehavioral Scale; OUD; Opioid Use Disorder;
Keywords: CR; controlled release; DSM-5; Diagnostic and Statistical Manual of Mental Diseases (Fifth Edition); IR; immediate release; LTOT; long-term opioid therapy; OUD; opioid use disorder; PCP; primary care provider;
Keywords: ASSIST; Alcohol, Smoking and Substance Involvement Screening Test; AUD; Alcohol use disorder; BT; Brief treatment; BUP/NX; Buprenorphine/naloxone; CC; Collaborative care; CI; Confidence interval; CIDI; Comprehensive International Diagnostic Interview; DSM
Keywords: GC-MS; gas chromatography-mass spectrometry; LC-MS-MS; liquid chromatography tandem mass spectrometry; LOQ; limit of quantitation; MAT; medication-assisted treatment; OTP; opioid treatment program; OUD; opioid use disorder; THC; tetrahydrocannabidiol;
Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach
Keywords: OUD; opioid use disorder; SUD; substance use disorder; OAT; opioid agonist treatment; PBM; pharmacy benefits manager; DSM-V; Diagnostic and Statistical Manual of Mental Disorders, 5th edition; NSDUH; National Survey on Drug Use and Health; CDC; Centers fo
Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine
Keywords: OUD; opioid use disorder; OBOT; Office Based Opioid Treatment; UDT; urine drug test; Buprenorphine; Patient dropout; Reengagement; Office Based Opioid Treatment (OBOT); Opioid-related disorders; Substance users;